跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-CITALOPRAM TABLETS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-CITALOPRAM TABLETS
Authorized
STANDARD
AG-CITALOPRAM TABLETS
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
bee1de358fe297fa
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
bee1de358fe297fa
Drug Approval Canada Name
AG-CITALOPRAM TABLETS
Product Name
AG-CITALOPRAM TABLETS
Status
Marketed
Status Date
2024-01-30
Original Market Date
2024-01-30
Din
02543060
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.20
Atc Original
N06AB04 CITALOPRAM
Atc Name
n 06 ab 04
Aig Number
0136243004
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
CITALOPRAM (CITALOPRAM HYDROBROMIDE)
30 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
bee1de358fe297fa
Type
Standard
Back to Health Canada Approvals